Advancing Treatments for Respiratory Health

Registration Deadline:

Event Contact:

  • Swapneeta Date

Explore other Industry Opportunities:

The “Advancing Treatments for Respiratory Health” initiative seeks groundbreaking technologies and solutions for COPD and asthma, emphasizing novel drug discovery and predictive modeling approaches. Projects should demonstrate clinical impact potential, promote collaboration, and drive respiratory health research forward.

What we're looking for: 

Seeking innovative solutions that improve the effectiveness and user experience of OTC treatments targeting the upper-respiratory track in respiratory conditions, including nasal congestion, sinusitis, asthma, COPD, and seasonal allergies.

Particularly interested in solutions that support individuals managing chronic respiratory conditions by enhancing natural nasal defenses, mitigating the impact of airborne pollutants, allergens, and pathogens, and promoting overall respiratory resilience.

Must-have requirements are:

  • Provides symptom relief or has the potential to improve the speed of symptom relief compared to existing OTC options
  • Reasonable likelihood of meeting OTC regulatory standards for safety, efficacy, and self-administration
  • Novel delivery methods and product formats must aim to improve patient adherence by enhancing tolerability, simplifying dosing, and/or ensuring ease of use

Nice-to-have requirements are:

  • Clinically demonstrated efficacy
  • Offers flavor and sensory enhancements to improve acceptability, or has minimal sensory impact (e.g., no strong taste, smell, or sting)
  • Delivers multi-symptom relief (e.g., congestion + allergy control)
  • Child-friendly or elderly-friendly (gentler delivery methods, easy administration)

Out of scope:

  • Prescription-only (Rx) drugs, unless supported by a clear path to OTC conversion
  • Cosmetic products lacking scientific evidence or therapeutic intent
  • Solutions targeting the lower respiratory tract

Please note: Faculty and researchers interested in applying for these opportunities based on technologies developed or disclosed at Vanderbilt must submit their proposals through the CTTC.